2011
DOI: 10.1016/j.avsg.2011.02.013
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Lower Extremity Revascularization on the Endothelial Functions Measured With Noninvasive Brachial Artery Flow-Mediated Dilatation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
25
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(29 citation statements)
references
References 16 publications
4
25
0
Order By: Relevance
“…The presented results indicate that similarly to other cardiologic syndromes (such as acute coronary syndromes or cardiogenic shock) most benefits from the medical interventions (in this case SFA stenting and intensification of pharmacotherapy) are observed in patients at the highest risk, such as patients with uncontrolled risk factors. Our results are partially consistent with limited data from the literature that confirm the beneficial effect of peripheral artery revascularization (involving mainly lower limbs and renal arteries) on all-cause and cardiovascular mortality [5,6,8,10,15,19,33] and improvement of global endothelial function [21,22]. In a randomized prospective study Husmann et al [21] demonstrated in 17 patients treated with a percutaneous procedure and pharmacotherapy due to peripheral arterial disease of the lower limbs that FMD values increased after 4 weeks of observation in contrast to patients treated only with pharmacotherapy (n = 16), in whom these values remained unchanged.…”
Section: Discussionsupporting
confidence: 81%
See 4 more Smart Citations
“…The presented results indicate that similarly to other cardiologic syndromes (such as acute coronary syndromes or cardiogenic shock) most benefits from the medical interventions (in this case SFA stenting and intensification of pharmacotherapy) are observed in patients at the highest risk, such as patients with uncontrolled risk factors. Our results are partially consistent with limited data from the literature that confirm the beneficial effect of peripheral artery revascularization (involving mainly lower limbs and renal arteries) on all-cause and cardiovascular mortality [5,6,8,10,15,19,33] and improvement of global endothelial function [21,22]. In a randomized prospective study Husmann et al [21] demonstrated in 17 patients treated with a percutaneous procedure and pharmacotherapy due to peripheral arterial disease of the lower limbs that FMD values increased after 4 weeks of observation in contrast to patients treated only with pharmacotherapy (n = 16), in whom these values remained unchanged.…”
Section: Discussionsupporting
confidence: 81%
“…In a randomized prospective study Husmann et al [21] demonstrated in 17 patients treated with a percutaneous procedure and pharmacotherapy due to peripheral arterial disease of the lower limbs that FMD values increased after 4 weeks of observation in contrast to patients treated only with pharmacotherapy (n = 16), in whom these values remained unchanged. On the other hand, Unal et al [22] found in a group of 54 patients that revascularization with the use of a femoro-popliteal PTFE prosthesis led to a significant rise of FMD values and decrease of the following markers in blood: nitric oxide, high-sensitivity C-reactive protein, interleukin-6 and tumor necrosis factor α (TNF-α). The authors of these studies proposed several potential mechanisms to explain the beneficial effect of peripheral revascularization on the global endothelial function: (a) secondary to increased physical activity increase of the shear stress, which is the most potent stimulus for endothelial production of nitric oxide [21], (b) reduction of oxidative stress caused by exertional ischemia before the procedure and by numerous episodes of post-ischemic reperfusion in the lower limb muscles [21], …”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations